News

May 25, 2016May 25, 2016

COPD Patients in US Face Significant Challenges in Accessing Treatment, Researchers Say

COPD, News

Leading U.S. experts in chronic obstructive pulmonary disease (COPD) have found that patients with the condition face substantial barriers in assessing care, with hospitals failing to provide recommended standard of care, ... Read more

May 24, 2016May 24, 2016

Potential PAH Treatment Shows Promising Preclinical Results

News, Pulmonary Hypertension

Reviva Pharmaceuticals recently announced promising preclinical efficacy data for RP5063, a novel dopamine-serotonin modulator for pulmonary arterial hypertension (PAH), at the American Thoracic Society (ATS) 2016 International Conference in California. RP5063 is ... Read more

May 24, 2016May 24, 2016

First Patient Dosed in Phase 2 Trial of Potential CF Treatment

Cystic Fibrosis, News

Nivalis Therapeutics, Inc., announced the first dosing of a cystic fibrosis (CF) patient enrolled in its second Phase 2 clinical trial evaluating the drug N91115, a stabilizer of the cystic fibrosis transmembrane conductance regulator ... Read more

May 24, 2016May 24, 2016

Bayer Ends Phase 2 Trial of Riociguat in PH Patients with Idiopathic Interstitial Pneumonias

News, Pulmonary Hypertension

Bayer has stopped a Phase 2 clinical trial (NCT02138825) evaluating riociguat (Adempas) in patients with pulmonary hypertension associated with idiopathic interstitial pneumonias (PH-IIP) on the recommendation of the study’s Data Monitoring Committee (DMC). The committee — sometimes ... Read more

May 23, 2016May 23, 2016

COPD Researchers Underscore Potential of Tailored, Holistic Approach to Treatment

COPD, News

The REG 2016 Annual Summit (Respiratory Effectiveness Group) on April 15–16 in Lyon, France, attracted several speakers who emphasized the need for more research into the nature and effectiveness of treatments for ... Read more

May 23, 2016May 23, 2016

Discovered Molecule May Prolong Life of Cystic Fibrosis Patients, Researchers Say

Cystic Fibrosis, News

Scientists at Queen’s University Belfast discovered a new molecule with the potential to prolong the life of individuals with cystic fibrosis (CF). The molecule, QUB-TL1, may be a potential treatment option for ... Read more

May 23, 2016May 23, 2016

Acute COPD Improved by Inhibitor, Approved Bronchodilators

COPD, News

Verona Pharma has announced positive results from the Phase 2a trial evaluating a phosphodiesterase (PDE) 3/4 inhibitor, RPL554, in patients with chronic obstructive pulmonary disorder (COPD). COPD is a progressive ... Read more

May 20, 2016May 20, 2016

Positive Data on COPD Therapy Breo Ellipta SUMMIT Study Presented by GSK

COPD, News

GlaxoSmithKline (GSK) and Innoviva recently presented positive results from two analyses of the SUMMIT trial, which investigated the efficacy and safety of Breo Ellipta (fluticasone furoate/vilanterol, or FF/VI 100/25 mcg) in patients with chronic obstructive pulmonary disease (COPD) ... Read more

May 20, 2016May 20, 2016

U. Washington Scientists’ Sensing Tool Measures Lung Function over Calls from any Phone, Anywhere

Asthma, COPD, Cystic Fibrosis, News

Most people in the developing world who live with asthma, cystic fibrosis, or other chronic lung diseases have no way of measuring the status of their lung function outside of ... Read more

May 20, 2016May 20, 2016

Follow-up Data from Study of EBV Treatment in Emphysema Patients Shows Lasting Benefits

Emphysema, News

Pulmonx Corporation reported positive one-year data from the STELVIO trial, the first randomized study evaluating the Zephyr Endobronchial Valve (EBV) in people with severe emphysema, who were selected using the diagnostic Chartis System to identify ... Read more